Category: Advances in Hematology
Weibel-Palade Bodies
J. Evan Sadler, MD, PhD Professor Departments of Medicine, Biochemistry and Molecular Biophysics Washington University School of Medicine St. Louis, Missouri H&O What are Weibel-Palade bodies? JS […]
The Safety of the Blood Supply
Paul Ness, MD Director, Division of Transfusion Medicine Professor of Pathology and Medicine Joint Appointment in Oncology The Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University […]
Sickle Cell Disease in Children
Winfred C. Wang, MD Department of Hematology St. Jude Children’s Research Hospital Memphis, Tennessee H&O Could you provide some background on sickle cell disease? WW In the United […]
Abnormal Partial Thromboplastin Time in Adults and Children
Rajiv K. Pruthi, MBBS Associate Professor of Medicine Mayo Clinic Rochester, Minnesota H&O What is the partial thromboplastin time (PTT) test? RP The coagulation cascade consists of 3 […]
Idiopathic Thrombocytopenic Purpura: Advances in Management
Cindy Neunert, MD, MSCS Assistant Professor Department of Pediatrics University of Texas Southwestern Medical Center at Dallas Dallas, Texas H&O What is idiopathic thrombocytopenic purpura (ITP) and […]
Treatment of Factor XI Deficiency
Louis M. Aledort, MD Professor of Medicine Hematology and Medical Oncology Mount Sinai Medical Center New York, New York H&O How does factor XI deficiency differ from […]
Autoimmune Lymphoproliferative Syndrome: New Approaches to Diagnosis and Management
David T. Teachey, MD Assistant Professor of Pediatrics Divisions of Hematology and Oncology Blood and Marrow Transplant Children’s Hospital of Philadelphia University of Pennsylvania School of […]
Treatment of Chemotherapy-Induced Anemia
George M. Rodgers, III, MD, PhD Professor, Divisions of Hematology and Oncology Department of Internal Medicine Huntsman Cancer Institute University of Utah Salt Lake City, Utah […]
The Hypercoagulability of Intravenous Immunoglobulin
Meir Mizrahi, MD Internal Medicine & Liver Units Hebrew University Hadassah Medical Center Jerusalem, Israel H&O What is intravenous immunoglobulin? MM Intravenous immunoglobulin (IVIG) is a solution of […]
Positive Blood Cultures
Melvin P. Weinstein, MD Professor of Medicine and Pathology Chief, Division of Infectious Diseases, Allergy & Immunology Robert Wood Johnson Medical School New Brunswick, New Jersey […]
Future Directions for Antiplatelet Drugs
Sergio Coccheri, MD Professor of Cardiovascular Medicine University of Bologna Bologna, Italy H&O What are some of the current options in antiplatelet therapy? SC The most common options […]
New Intravenous Iron Replacement Therapies
Michael Auerbach, MD Clinical Professor of Medicine Georgetown University School of Medicine Washington, DC H&O How common is anemia in cancer patients? MA Up to 70% of patients […]
The Importance of Antibody Detection and Identification in the Chronically Transfused Patient
S. Gerald Sandler, MD Professor of Medicine and Pathology Director, Transfusion Medicine Georgetown University Hospital Washington, DC H&O What types of patients require maintenance therapy with chronic […]
The Role of the Oncologist in the Management of VTE
Alok A. Khorana, MD, FACP Vice-Chief, Division of Hematology/Oncology Associate Professor of Medicine and Oncology James P. Wilmot Cancer Center University of Rochester Rochester, New York […]
Hypercoagulability and Recurrent Miscarriages
Benjamin Brenner, MD Professor of Hematology Caster Chair of Leukemia Research Director, Thrombosis and Hemostasis Unit Rambam Health Care Campus Technion-Israel Institute of Technology Haifa, Israel […]
Dietary Supplements and Oral Anticoagulants
Ann K. Wittkowsky, PharmD, CACP, FASHP, FCCP Clinical Professor University of Washington School of Pharmacy Director, Anticoagulation Services University of Washington Medical Center Seattle, Washington H&O Why is […]
Hormone-based Contraceptive Therapy and Risk of Venous Thromboembolism in Young Women
Helen Roberts, MB, MPH, FAChSHM Senior Lecturer Women’s Health Department of Obstetrics and Gynaecology University of Auckland Auckland, New Zealand H&O What do we know of the […]
Thrombophilia Evaluation: The Value of Testing Relatives
Thrombophilia Evaluation: The Value of Testing Relatives Kenneth A. Bauer, MD, Professor of Medicine, Harvard Medical School, Boston, Massachusetts H&O When testing for inherited thrombophilia, what factors should physicians look for? […]
Biosimilars: Considerations With Low Molecular Weight Heparins
Biosimilars: Considerations With Low Molecular Weight Heparins Craig M. Jackson, PhD, Formerly Professor of Biological Chemistry, Associate Professor of Internal Medicine, Washington University School of Medicine, St Louis, Missouri H&O What are […]
Drug-induced Immune Hemolytic Anemia
Drug-induced Immune Hemolytic Anemia George Garratty, PhD, FRCPath, Scientific Director American Red Cross Blood Services Southern California Region Pomona, California H&O What is the incidence/prevalence of drug induced immune hemolytic anemia (DIIHA)? […]